Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-12-001428
Filing Date
2012-05-15
Accepted
2012-05-15 15:22:45
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 AMEXDRUG CORPORATION 10Q 2012-03-31 amexdrug10q.htm 10-Q 391014
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANE amexdrug10qexh311.htm EX-31.1 14570
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANE amexdrug10qexh312.htm EX-31.2 14111
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANE amexdrug10qexh321.htm EX-32.1 6734
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES amexdrug10qexh322.htm EX-32.2 6683
  Complete submission text file 0001096906-12-001428.txt   1249325

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axrx-20120331.xml EX-101.INS 64623
7 XBRL TAXONOMY EXTENSION axrx-20120331.xsd EX-101.SCH 10560
8 XBRL TAXONOMY EXTENSION axrx-20120331_cal.xml EX-101.CAL 4762
9 XBRL TAXONOMY EXTENSION axrx-20120331_def.xml EX-101.DEF 49246
10 XBRL TAXONOMY EXTENSION axrx-20120331_lab.xml EX-101.LAB 88350
11 XBRL TAXONOMY EXTENSION SCHEMA axrx-20120331_pre.xml EX-101.PRE 62471
Mailing Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211
Business Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211 3108550475
AMEXDRUG CORP (Filer) CIK: 0000045621 (see all company filings)

EIN.: 952251025 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10304 | Film No.: 12844002
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries